Abstract:BACKGROUND & OBJECTIVE:Studying the mechanism of why the abnormal protein coded by mutant gene of hepatoma carcinoma cell possesses potential antigenicity, but can not form effective immunogen, searching for specific antigen of hepatoma, and developing DNA vaccine for hepatoma treatment will have active impact on the immunotherapy of hepatoma. This study was to construct fluorescent eukaryotic expression vector of mouse alpha fetoprotein (AFP) cDNA fragment with or without the secretory signal peptide (termed AFP1 cDNA and AFP2 cDNA), and observe its expression in mouse dendritic cells (DCs) and in vitro antitumor effect on hepatoma.METHODS:AFP1 cDNA and AFP2 cDNA were amplified from mouse hepatoma cell line H22 by reverse transcription-polymerase chain reaction (RT-PCR), and cloned into eukaryotic expression vector PEGF-N3 to form the recombinant PEGF-N3/AFP1 and PEGF-N3/AFP2. The mouse bone marrow cells were induced with recombinant granulocyte-macrophage colony-stimulating factor (rmGM-CSF) and recombinant interleukin-4 (rmIL-4) to form mature DCs. The recombinant PEGF-N3/AFP1 and PEGF-N3/AFP2 were transfected into DCs. The DCs vaccine were co-cultured with isogenous mouse spleen lymphocytes. The expression of gamma-interferon (IFN-gamma) in the spleen lymphocytes stimulated by AFP1/DCs or AFP2/DCs was measured by ELISA assay; the specific killing activity of cytotoxic T lymphocytes (CTLs) was evaluated by 51Cr release assay.RESULTS:Sequencing analysis verified that AFP1 cDNA and AFP2 cDNA were correctly amplified from H22 cells. The recombinant PEGF-N3/AFP1 and PEGF-N3/AFP2 were stably expressed in mouse DCs. AFP2/DCs obviously stimulated proliferation of T lymphocytes; the stimulation index (SI) was significantly higher in AFP2/DCs group than in AFP1/DCs group, empty vector group, and blank control group (5.12 +/- 1.46 vs. 1.41 +/- 0.65, 1.42 +/- 0.7, and 1.41 +/- 0.55, P < 0.01); the specific killing activity of CTLs was stronger in AFP2/DCs group than in empty vector group [(88.15 +/- 16.4)% vs. (12.72 +/- 5.45)%].CONCLUSION:The recombinant expression vectors PEGF-N3/AFP1 and PEGF-N3/AFP2 with or without signal peptide were constructed successfully. AFP2/DCs can specifically activate T lymphocytes in vitro and effectively induce antitumor immune response.

Construction of Pegfp-N3-apc Vectors Carrying Various APC Functional Domains and Their Expression in HCT-II6 Cells

Expression of Recombinant Pegfp-N3-apc Vectors in HT-29 Colorectal Carcinoma Cell Line

[Effect of Recombinant Pegfp-N3-apc Vectors Carrying Various APC Functional Domains on the Expression of Beta-Catenin in HT-29 Cells].

Construction of Recombinant Plasmid Pcgn-Ham-n1-wcapc and This Plasmid Inhibition of Activation of T-cell Factor/lymphocyte Enhancer Factor Promoter

Construction and Identification of Five Mutants of Hil-18 in Expression Plasmid and Their Expression in BxPC-3 Cells

Construction of Eukaryotic Expression Plasmids Containing Green Fluorescent Protein Gene and CYP19 WT or Its Variants

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Soluble Expression of Recombinant Apoptin Fused with Mutant Cell-penetrating Peptide

Construction and Functional Verification of AP-2 Gene Family Eukaryotic Expression Vector

Construction of Recombinant Plasmid Pegfp-Anxa5 and Its Expression in Hela Cells

Construction and Expression of Recombined Human AFP Eukaryotic Expression Vector

Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma

[Construction of Eukaryotic Expression Vector of Mouse Alpha-Fetoprotein Cdna and Its Expression in Dendritic Cells and in Vitro Antitumor Effect on Hepatoma].

The Construction and Expression of Eukaryotic EGFP Expression Vector Containing Hepatoma Assosciated Antigen HAb18G/CD147

Construction and expression of recombinant plasmid pIRES_2-HPV18-EGFP

Cloning of connective tissue growth factor gene and construction of recombinant adenovirus vector Ad5-CTGF

[Construction and Expression of Eukaryotic Expression Plasmid Pcdna3.1/hil-18].

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

The Construction of a Screening System of Human Amyloid Precursor Protein and Enhanced Fluorescence Protein Fusion Gene

Construction of expression plasmid of the mutant PUMA and its expression in Hela cells

Construction, Packaging and Titration of Recombinant Adeno-Associated Virus Vectors Contaning Antitumor Genes